Super Group (SGHC) Limited Ordinary Shares SGHC 深 滬
已收盤 09-19 16:00:00 美东时间
11.76
+0.070
+0.60%
華盛通- 最 高11.87
- 今 開11.82
- 成交量 497.58万股
- 最 低 11.35
- 昨 收 11.69
- 總市值 59.51亿
- 52周最高 13.71
- 市盈率 靜 48.41
- 換手率 0.00%
- 52周最低 3.22
- 委 比 99.30%
- 總股本 5.06亿
- 歷史最高 13.71
- 量 比 0.97
- 振 幅 4.45%
- 歷史最低 2.20
- 每 手 1
- 風險率 0.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 上调！CrowdStrike、Lyft、MongoDB、Roivant等多只热门股获大行齐上调目标价
今日重点评级关注：Needham：上调爱美医疗评级至"买入"，目标价14美元；高盛：维持Roivant Sciences"买入"评级，目标价从20美元升至24美元
09-19 09:18
Super Group (SGHC) Hosts Investor Day in London
Super Group (SGHC) ( ($SGHC) ) has shared an announcement. Super Group (SGHC) L...
09-18 04:37
Super Group Raises FY25 Guidance, Sees Revenue $2.125B-$2.2B; Adjusted EBITDA $550M-$560M
Super Group Raises Full-Year 2025 Group Revenue and Adjusted EBITDA Guidance • To date, third quarter performance exceeded expectations despite seasonality, with
09-18 04:08
美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
Macquarie Initiates Coverage On Super Group (SGHC) with Outperform Rating, Announces Price Target of $17
Macquarie analyst Chad Beynon initiates coverage on Super Group (SGHC) (NYSE:SGHC) with a Outperform rating and announces Price Target of $17.
09-16 02:44
A Peek at Boyd Gaming's Future Earnings
Boyd Gaming (NYSE:BYD) is gearing up to announce its quarterly earnings on Thur...
08-12 23:01
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
Benchmark Maintains Buy on Super Group (SGHC), Raises Price Target to $15
Benchmark analyst Mike Hickey maintains Super Group (SGHC) (NYSE:SGHC) with a Buy and raises the price target from $14 to $15.
08-07 20:15
Super Group (SGHC) Q2 Sales $579.40M Beat $498.18M Estimate
Super Group (SGHC) (NYSE:SGHC) reported quarterly sales of $579.40 million which beat the analyst consensus estimate of $498.18 million by 16.30 percent. This is a 29.76 percent increase over sales of $446.52 million
08-07 16:36
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
